Prof. Dr. med. Özgür Yaldizli

Einsiedler, Maximilian, Maceski, Aleksandra Maleska, Sandgren, Sofia, Oechtering, Johanna, Schaedelin, Sabine, Hofer, Lisa, Zadic, Amar, Gomez, Juan Francisco Vilchez, Melie-Garcia, Lester, Cagol, Alessandro, Galbusera, Riccardo, Finkener, Sebastian, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, Mathias, Amandine, Du Pasquier, Renaud, Hoepner, Robert, et al. (2025). Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response. Annals of Clinical and Translational Neurology, 12, 2214–2225. https://doi.org/10.1002/acn3.70149

Chen, Xinjie, Lu, Po-Jui, Ocampo-Pineda, Mario, Cagol, Alessandro, Schaedelin, Sabine Anna, Ruberte, Esther, Weigel, Matthias, Spagnolo, Federico, Benkert, Pascal, Lieb, Johanna Maria, Leppert, David, Yaldizli, Özgr, Oechtering, Johanna, D’Souza, Marcus, Fischer-Barnicol, Bettina, Derfuss, Tobias J., Ekerdt, Clara, Menks, Willeke M., Chan, Kwok-Shing, et al. (2025). Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis. Neurology Neuroimmunology and Neuroinflammation, 12. https://doi.org/10.1212/NXI.0000000000200459

Cagol, Alessandro, Schaedelin, Sabine, Ocampo-Pineda, Mario, Benkert, Pascal, Melie-Garcia, Lester, Luchetti, Ludovico, Yaldizli, Özgür, Oechtering, Johanna, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Finkener, Sebastian, Vehoff, Jochen, Disanto, Giulio, Chan, Andrew, Pot, Caroline, Zecca, Chiara, Derfuss, Tobias, Lieb, Johanna M., et al. (2025). Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort. Journal of Neurology, 272. https://doi.org/10.1007/s00415-025-13221-x

Einsiedler, Maximilian, Zecca, Chiara, Hofer, Lisa, Benkert, Pascal, Axfors, Cathrine, Bedussi, Francesca, Ceschi, Alessandro, Disanto, Giulio, Müller, Jannis, Oechtering, Johanna, Lorscheider, Johannes, Galli, Edoardo, Fischer-Barnicol, Bettina, D’Souza, Marcus, Schaedelin, Sabine Anna, Maceski, Aleksandra Maleska, Hoepner, Robert, Chan, Andrew, Granziera, Cristina, et al. (2025). Treatment Strategies and Disease Activity During Pregnancy and Postpartum Real-World Data From the Swiss Multiple Sclerosis Cohort. Neurology Clinical Practice, 15. https://doi.org/10.1212/CPJ.0000000000200499

Yaldizli, Özgür, Benkert, Pascal, Achtnichts, Lutz, Bar-Or, Amit, Bohner-Lang, Viviane, Bridel, Claire, Comabella, Manuel, Findling, Oliver, Disanto, Giulio, Finkener, Sebastian, Gobbi, Claudio, Granziera, Cristina, Herwerth, Marina, Hoepner, Robert, Horakova, Dana, Kamber, Nicole, Khalil, Michael, Kunz, Philipp, Lalive, Patrice, et al. (2025). Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. Multiple Sclerosis Journal, 31, 932–943. https://doi.org/10.1177/13524585251335466

Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, et al. (2025). Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 82(6), 614–625. https://doi.org/10.1001/jamaneurol.2025.0495

Iaquinto, Stefania, Ineichen, Benjamin Victor, Stanikić, Mina, Kuhle, Jens, Kamm, Christian Philipp, Calabrese, Pasquale, Roth, Patrick, Baum, Claudia, Zecca, Chiara, Gobbi, Claudio, Yaldizli, Özgür, Puhan, Milo Alan, von Wyl, Viktor, Anderseck, Bernd, Baum, Claudia, Calabrese, Pasquale, Chan, Andrew, Disanto, Giulio, Engelhardt, Britta, et al. (2025). Confirmed Worsening of Health-Related Quality of Life to Monitor Long-Term MS Disease Progression: A Longitudinal Analysis From the Swiss Multiple Sclerosis Registry. European Journal of Neurology, 32. https://doi.org/10.1111/ene.70230

Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Horakova, Dana, Kubala Havrdova, Eva, Eichau, Sara, Patti, Francesco, Grammond, Pierre, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Grand’Maison, Francois, Alroughani, Raed, Lechner-Scott, Jeannette, Spitaleri, Daniele, Barnett, Michael, Cartechini, Elisabetta, Sa, Maria Jose, et al. (2025). Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study. CNS Drugs, 39(4), 403–416. https://doi.org/10.1007/s40263-025-01164-w

Benkert, Pascal, Maleska Maceski, Aleksandra, Schaedelin, Sabine, Oechtering, Johanna, Zadic, Amar, Vilchez Gomez, Juan Francisco, Melie‐Garcia, Lester, Cagol, Alessandro, Galbusera, Riccardo, Subramaniam, Suvitha, Lorscheider, Johannes, Galli, Edoardo, Mueller, Jannis, Fischer‐Barnicol, Bettina, Achtnichts, Lutz, Findling, Oliver, Lalive, Patrice H., Bridel, Claire, Uginet, Marjolaine, et al. (2025). Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis. Annals of Neurology, 97(1), 104–115. https://doi.org/10.1002/ana.27096

Disanto, Giulio, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Galbusera, Riccardo, Finkener, Sebastian, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Hoepner, Robert, Salmen, Anke, Zecca, Chiara, Hemkens, Lars G, D’Souza, Marcus, Fischer-Barnicol, Bettina, Du Pasquier, Renaud, Roth, Patrick, Yaldizli, Özgür, et al. (2025). Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 11. https://doi.org/10.1177/20552173251315457

Durrer, Alicia, Wolleb, Julia, Bieder, Florentin, Friedrich, Paul, Melie-Garcia, Lester, Ocampo Pineda, Mario Alberto, Bercea, Cosmin I., Hamamci, Ibrahim Ethem, Wiestler, Benedikt, Piraud, Marie, Yaldizli, Oezguer, Granziera, Cristina, Menze, Bjoern, Cattin, Philippe C., & Kofler, Florian. (2025). Denoising Diffusion Models for 3D Healthy Brain Tissue Inpainting. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) , 15224 LNCS, 87–97. https://doi.org/10.1007/978-3-031-72744-3_9

Hench, J., Hultschig, C., Bratic Hench, I., Sadasivan, H., Yaldizli, Ö., Hutter, G., Dirnhofer, S., Tzankov, A., & Frank, S. (2024). Rapid brain lymphoma diagnostics through nanopore sequencing of cytology-negative cerebrospinal fluid. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02793-z

Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25. https://doi.org/10.1186/s13063-024-08454-6

Cortese, Rosa, Battaglini, Marco, Prados, Ferran, Gentile, Giordano, Luchetti, Ludovico, Bianchi, Alessia, Haider, Lukas, Jacob, Anu, Palace, Jacqueline, Messina, Silvia, Paul, Friedemann, Marignier, Romain, Durand-Dubief, Françoise, de Medeiros Rimkus, Carolina, Apostolos Pereira, Samira Luisa, Sato, Douglas Kazutoshi, Filippi, Massimo, Rocca, M.A., Cacciaguerra, Laura, et al. (2024). Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of Neurology, 96(2), 276–288. https://doi.org/10.1002/ana.26951

Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, Kuhle, Jens, Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior, 14(5). https://doi.org/10.1002/brb3.3498

Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, Kuhle, Jens, Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938

Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, Kuhle, Jens, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia. The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3

Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768

Iaquinto, Stefania, Chan, Andrew, Manjaly, Zina-Mary, Stanikić, Mina, Ineichen, Benjamin Victor, Kuhle, Jens, Haag, Christina, Müller, Jannis, Yaldizli, Özgür, Kamm, Christian Philipp, Calabrese, Pasquale, Zecca, Chiara, Magnusson, Tomas, Ammann, Sabin, Kesselring, Jürg, Baum, Claudia, Kaminski, Miriam, Puhan, Milo Alan, & Von Wyl, Viktor. (2024). Rising Prevalence of Multiple Sclerosis in Switzerland: Results from the Swiss Multiple Sclerosis Registry. Neuroepidemiology. https://doi.org/10.1159/000542632

Mueller, Simon M., Zhu, Jie, Brandt, Oliver, Navarini, Alexander A., Yaldizli, Oezguer, Papadopoulou, Athina, & Kuhle, Jens. (2024). Serum Neurofilament Light Chain Levels Correlate With Skin Inflammation and Scratch Lesions in Patients With Pruritus. Dermatologic Therapy, 2024. https://doi.org/10.1155/2024/3542876

Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, Kuhle, Jens, Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis. European Journal of Neurology, 30(12), 3809–3818. https://doi.org/10.1111/ene.16044

Stanikić, Mina, Braun, Julia, Ajdacic-Gross, Vladeta, Manjaly, Zina-Mary, Yaldizli, Özgür, Ineichen, Benjamin Victor, Kamm, Christian P., Iaquinto, Stefania, Gobbi, Claudio, Zecca, Chiara, Calabrese, Pasquale, & von Wyl, Viktor. (2023). Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type. Multiple Sclerosis and Related Disorders, 80. https://doi.org/10.1016/j.msard.2023.105097

Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, Kuhle, Jens, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review. JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331

Cortese R., Battaglini M., Prados F., Bianchi A., Haider L., Jacob A., Palace J., Messina S., Paul F., Wuerfel J., Marignier R., Durand-Dubief F., de Medeiros Rimkus C., Callegaro D., Sato D.K., Filippi M., Rocca M.A., Cacciaguerra L., Rovira A., et al. (2023). Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain, 146(6), 2489–2501. https://doi.org/10.1093/brain/awac480

Meier, Stephanie, Willemse, Eline A.J., Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, et al. (2023). Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurology, 80(3), 287–297. https://doi.org/10.1001/jamaneurol.2022.5250

Cerdá-Fuertes, Nuria, Nagy, Sara, Schaedelin, Sabine, Sinnecker, Tim, Ruberte, Esther, Papadopoulou, Athina, Würfel, Jens, Kuhle, Jens, Yaldizli, Özgür, Kappos, Ludwig, Derfuss, Tobias, & Décard, Bernhard F. (2023). Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150312

Durrer, Alicia, Wolleb, Julia, Bieder, Florentin, Sinnecker, Tim, Weigel, Matthias, Sandkühler, Robin, Granziera, Cristina, Yaldizli, Özgür, & Cattin, Philippe C. (2023). Diffusion Models for Contrast Harmonization of Magnetic Resonance Images. Proceedings of Machine Learning Research, 227, 526–551.

Etter, Manina M., Martins, Tomás A., Kulsvehagen, Laila, Pössnecker, Elisabeth, Duchemin, Wandrille, Hogan, Sabrina, Sanabria-Diaz, Gretel, Müller, Jannis, Chiappini, Alessio, Rychen, Jonathan, Eberhard, Noëmi, Guzman, Raphael, Mariani, Luigi, Melie-Garcia, Lester, Keller, Emanuela, Jelcic, Ilijas, Pargger, Hans, Siegemund, Martin, Kuhle, Jens, et al. (2022). Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nature Communications, 13. https://doi.org/10.1038/s41467-022-34068-0

Yaldizli Ö, & Derfuss T. (2022). All Bruton’s tyrosine kinase inhibitors have similar efficacy and risks: Commentary (Patent No. 10). Multiple Sclerosis Journal, 28(10), Article 10. https://doi.org/10.1177/13524585221097562

Cagol, Alessandro, Schaedelin, Sabine, Barakovic, Muhamed, Benkert, Pascal, Todea, Ramona-Alexandra, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Melie-Garcia, Lester, Ruberte, Esther, Siebenborn, Nina, Battaglini, Marco, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Sinnecker, Tim, Lorscheider, Johannes, Fischer-Barnicol, Bettina, et al. (2022). Association of Brain Atrophy with Disease Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis. JAMA Neurology, 79, 682–692. https://doi.org/10.1001/jamaneurol.2022.1025

Müller, Jannis, Sinnecker, Tim, Wendebourg, Maria Janina, Schläger, Regina, Kuhle, Jens, Schädelin, Sabine, Benkert, Pascal, Derfuss, Tobias, Cattin, Philippe, Jud, Christoph, Spiess, Florian, Amann, Michael, Lincke, Therese, Barakovic, Muhamed, Cagol, Alessandro, Tsagkas, Charidimos, Parmar, Katrin, Pröbstel, Anne-Katrin, Reimann, Sophia, et al. (2022). Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis. Neurology: Neuroimmunology and NeuroInflammation, 9(3). https://doi.org/10.1212/nxi.0000000000001147

Benkert, Pascal, Meier, Stephanie, Schaedelin, Sabine, Manouchehrinia, Ali, Yaldizli, Özgür, Maceski, Aleksandra, Oechtering, Johanna, Achtnichts, Lutz, Conen, David, Derfuss, Tobias, Lalive, Patrice H., Mueller, Christian, Müller, Stefanie, Naegelin, Yvonne, Oksenberg, Jorge R., Pot, Caroline, Salmen, Anke, Willemse, Eline, Kockum, Ingrid, et al. (2022). Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. The Lancet Neurology, 21(3), 246–257. https://doi.org/10.1016/s1474-4422(22)00009-6

Sinnecker, Tim, Schädelin, Sabine, Benkert, Pascal, Ruberte, Esther, Amann, Michael, Lieb, Johanna M., Naegelin, Yvonne, Müller, Jannis, Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Wuerfel, Jens, Granziera, Cristina, & Yaldizli, Özgür. (2022). Brain atrophy measurement over a MRI scanner change in multiple sclerosis. NeuroImage: Clinical, 36. https://doi.org/10.1016/j.nicl.2022.103148

Wolleb, Julia, Sandkühler, Robin, Bieder, Florentin, Barakovic, Muhamed, Hadjikhani, Nouchine, Papadopoulou, Athina, Yaldizli, Özgür, Kuhle, Jens, Granziera, Cristina, & Cattin, Philippe C. (2022). Learn to Ignore: Domain Adaptation for Multi-site MRI Analysis. Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 13437 LNCS, 725–735. https://doi.org/10.1007/978-3-031-16449-1_69

Cagol, A., Schaedelin, S., Barakovic, M., Benkert, P., Todea, R. -A., Rahmanzadeh, R., Galbusera, R., Lu, P. -J., Weigel, M., Melie-Garcia, L., Ruberte, E., Radue, E. -W., Yaldizli, O., Oechtering, J., Sinnecker, T., Lorscheider, J., Mueller, S., Achtnichts, L., Vehoff, J., et al. (2021). Progression independent of relapse activity is associated with increased brain atrophy rates in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 27(2), 98–99.

Oechtering, Johanna, Schaedelin, Sabine, Benkert, Pascal, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, Fischer-Barnicol, Bettina, Orleth, Annette, Chan, Andrew, Pot, Caroline, Barakovic, Muhamed, Rahmanzadeh, Reza, Galbusera, Riccardo, Heijnen, Ingmar, Lalive, Patrice H., Wuerfel, Jens, Subramaniam, Suvitha, et al. (2021). Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Annals of Neurology, 90, 477–489. https://doi.org/10.1002/ana.26137

Allum, J.H.J., Rust, H.M., Lutz, N., Schouenborg, C., Fischer-Barnicol, B., Haller, V., Derfuss, T., Kuhle, J., & Yaldizli, Ö. (2021). Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patients. Journal of the Neurological Sciences, 425. https://doi.org/10.1016/j.jns.2021.117432

Tsagkas, Charidimos, Schäfer, Silke, Baumgartner, Annette, Müller, Jannis, Sinnecker, Tim, Mehling, Matthias, van der Stouwe, Jan Gerrit, Felder, Susan, Panagiotou, Anneza, Potlukova, Eliska, Winzeler, Bettina, Scholz, Marleen Carina, Timper, Katharina, Blackham, Kristine, Nickel, Christian H, Christ-Crain, Mirjam, Bingisser, Roland, Lyrer, Philippe, Kappos, Ludwig, & Yaldizli, Özgür. (2021). Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica. Lancet, 397, 2194. https://doi.org/10.1016/S0140-6736(21)00986-7

Lorscheider J, Benkert P, Lienert C, Hänni P, Derfuss T, Kuhle J, Kappos L., & Yaldizli Ö. (2021). Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis. Journal of Neurology, 268(3), 941–949. https://doi.org/10.1007/s00415-020-10226-6

von Wyl V, Benkert P, Moser A, Lorscheider J, Décard B, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, & Yaldizli Ö. (2021). Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate. Multiple Sclerosis Journal, 27(3), 439–448. https://doi.org/10.1177/1352458520918489

Todea, R. -A., Melie-Garcia, L., Barakovic, M., Siebenborn, N., Rahmanzadeh, R., Galbusera, R., Lu, P. -J., Weigel, M., Ruberte, E., Radue, E. W., Schadelin, S., Benkert, P., Yaldizli, O., Oechtering, J., Sinnecker, T., Mueller, S., Achtnichts, L., Vehoff, J., Disanto, G., et al. (2021). Leman-PV as a clinical decision-support tool to assess MS activity: a multicentric longitudinal study at 1.5T and 3T MRI. Multiple Sclerosis Journal, 27(2).

Sander, Laura, Horvath, Antal, Pezold, Simon, Andermatt, Simon, Amann, Michael, Sinnecker, Tim, Wendebourg, Maria J., Kesenheimer, Eva, Yaldizli, Özgür, Kappos, Ludwig, Granziera, Cristina, Wuerfel, Jens, Cattin, Philippe, & Schlaeger, Regina. (2020). Improving Accuracy of Brainstem MRI Volumetry: Effects of Age and Sex, and Normalization Strategies. Frontiers in Neuroscience, 14. https://doi.org/10.3389/fnins.2020.609422

Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, & Benedict RH. (2020). Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study. Multiple Sclerosis Journal, 26(13), 1670–1681. https://doi.org/10.1177/1352458519881428

Kronlage, Cornelius, Hardmeier, Martin, Bally, Seraina, Scholz, Marleen Carina, Bucher, Heiner C, Müller, Olivia Katharina, Winterhalder, Clemens, Mongiat, Michel, Müller, Jannis, Polymeris, Alexandros, Weber, Martin, Lausberg, Christina, Kassi, Elianne, Kuhle, Jens, Kappos, Ludwig, Hermann, Wieland, Bernsmeier, Christine, & Yaldizli, Özgür. (2020). Muscle stiffness, gait instability, and liver cirrhosis in Wilson’s disease. The Lancet, 396(10256), 990. https://doi.org/10.1016/s0140-6736(20)31963-2

von Wyl V, Décard BF, Benkert P, Lorscheider J, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, & Yaldizli Ö. (2020). Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment. European Journal of Neurology, 27(6), 1066–1075. https://doi.org/10.1111/ene.14191

Benkert, P., Schaedelin, S., Maceski, A., Disanto, G., Oechtering, J., Barakovic, M., Orleth, A., Rey, D., Sinnecker, T., Yaldizli, O., Rahmanzadeh, R., Zadic, S., Galbusera, R., Todea, R. -A., Cagol, A., Achtnichts, L., Aeschbacher, S., Chan, A., Conen, D., et al. (2020). Serum nfl z-scores derived from a large healthy control group reflect different levels of treatment effect in a real-world setting. Multiple Sclerosis Journal, 26(3, Supplement), 194–195.

Cagol, A., Barakovic, M., Benkert, P., Todea, R. -A., Rahmanzadeh, R., Galbusera, R., Schaedelin, S., Lu, P. -J., Weigel, M., Radue, E. -W., Yaldizli, O., Lorscheider, J., Sinnecker, T., Fartaria, M. J., Mueller, S., Achtnichts, L., Vehoff, J., Disanto, G., Findling, O., et al. (2020). Focal inflammatory activity and lesion repair are associated with brain atrophy rates in MS patients. Multiple Sclerosis Journal, 26(3, Supplement), 395.

Oechtering, J., Schaedelin, S., Benkert, P., Barakovic, M., Maceski, A., Orleth, A., Rey, D., Sinnecker, T., Rahmanzadeh, R., Zadic, S., Galbusera, R., Todea, R. -A., Cagol, A., Achtnichts, L., Aeschbacher, S., Berger, K., Chan, A., Conen, D., Derfuss, T., et al. (2020). Intrathecal immunoglobulin m synthesis is associated with higher serum neurofilament light chain levels and increased mri disease activity in ms. Multiple Sclerosis Journal, 26(3, Supplement), 165.

Sinnecker, Tim, Ruberte, Esther, Schädelin, Sabine, Canova, Vera, Amann, Michael, Naegelin, Yvonne, Penner, Iris-Katharina, Müller, Jannis, Kuhle, Jens, Décard, Bernhard, Derfuss, Tobias, Kappos, Ludwig, Granziera, Cristina, Wuerfel, Jens, Magon, Stefano, & Yaldizli, Özgür. (2020). New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis [Journal-article]. Journal of Neurology, 267(1), 192–202. https://doi.org/10.1007/s00415-019-09565-w

Sinnecker, T., Ruberte, E., Yaldizli, O., Rahmanzadeh, R., Galbusera, R., Todea, R. -A., Cagol, A., Subramaniam, S., Benkert, P., Mueller, S., Achtnichts, L., Vehoff, J., Disanto, G., Findling, O., Chan, A., Salmen, A., Pot, C., Lalive, P., Zecca, C., et al. (2020). Role of gadolinium-based contrast agents to detect subclinical disease activity in clinically stable patients in the swiss MS cohort study. Multiple Sclerosis Journal, 26(3, Supplement), 422–423.

Yaldizli, O., Benkert, P., Maceski, A., Barakovic, M., Todea, R. -A., Cagol, A., Schaedelin, S., Disanto, G., Oechtering, J., Orleth, A., Rey, D., Sinnecker, T., Rahmanzadeh, R., Zadic, S., Galbusera, R., Achtnichts, L., Aeschbacher, S., Chan, A., Conen, D., et al. (2020). Value of serum neurofilament light chain levels as a biomarker of suboptimal treatment response in MS clinical practice. Multiple Sclerosis Journal, 26(3, Supplement), 26–27.

Kaufmann M, Puhan MA, Kuhle J, Yaldizli Ö, Magnusson T, Kamm CP, Calabrese P, & von Wyl V. (2019). A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis. Frontiers in Neurology, 10, 953. https://doi.org/10.3389/fneur.2019.00953

Ruberte, Esther, Sinnecker, Tim, Amann, Michael, Gaetano, Laura, Naegelin, Yvonne, Penner, Iris-Katharina, Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Granziera, Cristina, Wuerfel, Jens, & Yaldizli, Özgür. (2019). Central slab versus whole brain to measure brain atrophy in multiple sclerosis. European Neurology, 80(3-4), 207–214. https://doi.org/10.1159/000495798

Findling O, Rust H, Yaldizli Ö, Timmermans DPH, Scheltinga A, & Allum JHJ. (2018). Balance changes in patients with relapsing-remitting multiple sclerosis: A pilot study comparing the dynamics of the relapse and remitting phases. Frontiers in Neurology, 9(AUG), 686. https://doi.org/10.3389/fneur.2018.00686

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, & Kuhle J. (2018). Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain, 141(8), 2382–2391. https://doi.org/10.1093/brain/awy154

Lorscheider J, Benkert P, Lienert C, Hänni P, Derfuss T, Kuhle J, Kappos L, & Yaldizli Ö. (2018). Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing–remitting multiple sclerosis. Multiple Sclerosis Journal, 24(6), 777–785. https://doi.org/10.1177/1352458518768433

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, & Wolinsky JS. (2018). Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study. Annals of Clinical and Translational Neurology, 5(3), 346–356. https://doi.org/10.1002/acn3.534

Neuhaus M, Bagutti S, Yaldizli Ö, Zwahlen D, Schaub S, Frey B, Fischer-Barnicol B, Burgunder JM, Martory MD, Pöttgen J, Annoni JM, & Penner IK. (2018). Characterization of social cognition impairment in multiple sclerosis. European Journal of Neurology, 25(1), 90–96. https://doi.org/10.1111/ene.13457

Lorscheider, J., Benkert, P., Lienert, C., Hanni, P., Schmid, J., Derfuss, T., Kuhle, J., Kappos, L., & Yaldizli, O. (2017). Fingolimod vs. dimethyl fumarate in relapsing-remitting multiple sclerosis: propensity score matched comparison in a large observational data set [SAGE PUBLICATIONS LTD]. 23, 601–602. https://doi.org/10.26226/morressier.59a3edabd462b8028d895259

D’Souza M, Yaldizli Ö, John R, Vogt DR, Papadopoulou A, Lucassen E, Menegola M, Andelova M, Dahlke F, Schnyder F, & Kappos L. (2017). Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study. Multiple Sclerosis, 23(4), 597–603. https://doi.org/10.1177/1352458516657439

Kuhle J, Nourbakhsh B, Grant D, Morant S, Barro C, Yaldizli Ö, Pelletier D, Giovannoni G, Waubant E, & Gnanapavan S. (2017). Serum neurofilament is associated with progression of brain atrophy and disability in early MS. Neurology, 88(9), 826–831. https://doi.org/10.1212/wnl.0000000000003653

Pardini, M, Botzkowski, D, Müller, S, Vehoff, J, Kuhle, J, Ruberte, E, Würfel, J, Gass, A, Valmaggia, C, Tettenborn, B, Putzki, N, & Yaldizli, Ö. (2016). The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. European Journal of Neurology, 23(12), 1769–1774. https://doi.org/10.1111/ene.13116

Pardini M, Sudre CH, Prados F, Yaldizli Ö, Sethi V, Muhlert N, Samson RS, van de Pavert SH, Cardoso MJ, Ourselin S, Gandini Wheeler-Kingshott CA, Miller DH, & Chard DT. (2016). Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 87(11), 1212–1217. https://doi.org/10.1136/jnnp-2016-313979

Callegari, Ilaria, Mattei, Chiara, Benassi, Francesca, Krueger, Frank, Grafman, Jordan, Yaldizli, Özgür, Sassos, Davide, Massucco, Davide, Scialò, Carlo, Nobili, Flavio, Serrati, Carlo, Amore, Mario, Cocito, Leonardo, Emberti Gialloreti, Leonardo, & Pardini, Matteo. (2016). Agomelatine improves apathy in frontotemporal dementia. Neurodegenerative Diseases, 16(5-6), 352–356. https://doi.org/10.1159/000445873

van der Logt RP, Findling O, Rust H, Yaldizli O, & Allum JH. (2016). The effect of vibrotactile biofeedback of trunk sway on balance control in multiple sclerosis. Multiple Sclerosis and Related Disorders, 8, 58–63. https://doi.org/10.1016/j.msard.2016.05.003

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CA, Yousry TA, Houlden H, Hardy J, Miller DH, & Chard DT. (2016). HLA-DRB∗1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis. Multiple Sclerosis and Related Disorders, 7, 47–52. https://doi.org/10.1016/j.msard.2016.03.003

Datta, Gourab, Battaglini, Marco, Scott, Gregory, Yaldizli, Ozgur, Santos-Ribeiro, Andre, Rabiner, Eugenii, Gunn, Roger, Owen, David, Malik, Omar, Ciccarelli, Olga, Nicholas, Richard, Langdon, Dawn, De Stefano, Nicola, & Matthews, Paul. (2016). Cortical [11C]PBR28 PET Measures of Microglial Inflammation Explain Differences in Cognitive Performance of People with MS. NEUROLOGY, 86.

Yaldizli Ö, Penner I.-K., Yonekawa T, Naegelin Y, Kuhle J, Pardini M., Chard DT, Stippich C, Kira JI, Bendfeldt K., Amann M., Radue EW, Kappos L, & Sprenger T. (2016). The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis. European Journal of Neurology, 23(3), 510–519. https://doi.org/10.1111/ene.12891

Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, & Chard DT. (2016). Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study. Multiple Sclerosis, 22(2), 150–159. https://doi.org/10.1177/1352458515586085

Pardini M, Cordano C, Guida S, Grafman J, Krueger F, Sassos D, Massucco D, Abate L, Yaldizli Ö, Serrati C, Amore M, Mattei C, Cocito L, & Emberti Gialloreti L. (2016). Prevalence and cognitive underpinnings of isolated apathy in young healthy subjects. Journal of Affective Disorders, 189, 272–275. https://doi.org/10.1016/j.jad.2015.09.062

Pardini M, Yaldizli Ö, Sethi V, Muhlert N, Liu Z, Samson RS, Altmann DR, Ron MA, Wheeler-Kingshott CA, Miller DH, & Chard DT. (2015). Motor network efficiency and disability in multiple sclerosis. Neurology, 85(13), 1115–1122. https://doi.org/10.1212/wnl.0000000000001970

Liu Z, Pardini M, Yaldizli Ö, Sethi V, Muhlert N, Wheeler-Kingshott CA, Samson RS, Miller DH, & Chard DT. (2015). Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain, 138(5), 1239–1246. https://doi.org/10.1093/brain/awv065

Liu Z, Yaldizli Ö, Pardini M, Sethi V, Kearney H, Muhlert N, Wheeler-Kingshott C, Miller DH, & Chard DT. (2015). Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis. Multiple Sclerosis and Related Disorders, 4(1), 52–57. https://doi.org/10.1016/j.msard.2014.11.004

Chard,DT, Liu,Z, Pardini,M, Yaldizli,O, Sethi,V, Muhlert,N, Wheeler-Kingshott,CAM, Samson,RS, & Miller,DH. (2015). Association of Multiple Sclerosis Normal Appearing White Matter Abnormality with Periventricular Location and Secondary Progression. Annual Meeting American Academy of Neurology, P6.

Pardini,M, Yaldizli,O, Sethi,V, Muhlert,N, Liu,Z, Samson,RS, Altmann,DR, Ron,MA, Wheeler-Kingshott,CAM, Miller,DHM, & Chard,DT. (2015). The relationship of a multi-parameter MRI measure of motor network efficiency with disability in multiple sclerosis. Annual Meeting American Academy of Neurology, P6.

Yaldizli,O, Pardini,M, Sethi,V, Muhlert,N, Liu,Z, Tozer,DJ, Samson,RS, Wheeler-Kingshott,CAM, Yousry,TA, Miller,DH, & Chard,DT. (2015). Diffusion Tensor Imaging Abnormalities in Multiple Sclerosis Cortical Lesions and Normal-Appearing Grey Matter and their Associations with Disability. Annual Meeting American Academy of Neurology, P6.

Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, et al. (2014). Multiple sclerosis registries in Europe - Results of a systematic survey. Multiple Sclerosis Journal, 20(11), 1523–1532. https://doi.org/10.1177/1352458514528760

Papadopoulou, A., Menegola, M., Kuhle, J., Ramagopalan, S. V., D’Souza, M., Sprenger, T., Radue, E. W., Kappos, L., & Yaldizli, O. (2014). Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 20(3), 30–322. https://doi.org/10.1177/1352458513495583

Papadopoulou A, Naegelin Y, Weier K, Amann M, Hirsch J, von Felten S, Yaldizli O, Sprenger T, Radue EW, Kappos L, & Gass A. (2014). MRI characteristics of periaqueductal lesions in multiple sclerosis. Multiple Sclerosis and Related Disorders, 3(4), 542–551. https://doi.org/10.1016/j.msard.2014.01.001

Pardini M, Uccelli A, Grafman J, Yaldizli Ö, Mancardi G, & Roccatagliata L. (2014). Isolated cognitive relapses in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 85(9), 1035–1037. https://doi.org/10.1136/jnnp-2013-307275

Yaldizli, O., Penner, I. K., Frontzek, K., Naegelin, Y., Amann, M., Papadopoulou, A., Sprenger, T., Kuhle, J., Calabrese, P., Radu, E. W., Kappos, L., & Gass, A. (2014). The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Multiple Sclerosis Journal, 20(3), 356–364. https://doi.org/10.1177/1352458513496880

Pardini,M, Sethi,V, Muhlert,N, Yaldizli,O, Palesi,F, Altmann,D, Ron,M, Wheeler-Kingshott,CAM, Miller,DH, & Chard,DT. (2014). Network Efficiency As A Final Common Pathway For Cognitive Deficits In Multiple Sclerosis: A Single Network Graph Theory Study. Annual Meeting American Academy of Neurology, P6.

van Dijk, Jitse P., Havlikova, Eva, Rosenberger, Jaroslav, Nagyova, Iveta, Skorvanek, Matej, Gdovinova, Zuzana, Lok, Willem, Groothoff, Johan W., & Middel, Berrie. (2013). Influence of disease severity on fatigue in patients with parkinson’s disease is mainly mediated by symptoms of depression. European Neurology, 70(3-4), 201–209. https://doi.org/10.1159/000351779

Hafner P, Yaldizli O, & Baumann T. (2013). Schwindel aus neurologischer Sicht unter spezieller Berücksichtigung von Notfallsituationen. Therapeutische Umschau. Revue Therapeutique, 70(1), 4–12. https://doi.org/10.1024/0040-5930/a000356

Yaldizli O., Kuhle J., Derfuss T., Sprenger T., & Kappos L. (2013). Neurologist-in-training: Multiple sclerosis. Schweizer Archiv Fur Neurologie Und Psychiatrie, 164(1), 37–40. https://doi.org/10.4414/sanp.2013.00103

Hafner,Patricia, Yaldizli,Özgür, & Baumann,Thomas. (2013). Schwindel aus neurologischer Sicht unter spezieller Berücksichtigung von Notfallsituationen. Ther Umsch, 70(3), 4–12.

Zwahlen,D, Schaub,S, Yaldizli,O, Opwis,K, Annoni,JM, Kappos,L, & Penner,IK. (2013). Theory of mind deficits in patients with multiple sclerosis – a separate entity of socio-cognitive impairment? ECTRIMS 2013, 990.

Lienert,C, Schoetzau,A, Beer,S, Kappos,L, & Yaldizli,O. (2012). Immunomodulatory treatment of multiple sclerosis in Switzerland – a nationwide follow-up of 8046 patients. ECTRIMS 2012, 213.

Yonekawa,T, Penner,IK, Naegelin,Y, Kuhle,J, Stippich,C, Radue,EWR, Kappos,L, Sprenger,T, & Yaldizli,O. (2012). Olfactory bulb volume and neuropsychological performance, fatigue severity and depression in multiple sclerosis patients. ECTRIMS 2012, 378.

Yaldizli Ö, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, & Putzki N. (2011). Fatigue and progression of corpus callosum atrophy in multiple sclerosis. Journal of Neurology, 258(12), 2199–2205. https://doi.org/10.1007/s00415-011-6091-0

Yaldizli O., Kuhle,J, Derfuss T., Sprenger T., & Kappos,L. (2011). Neurologist-in-training. Schweizer Archiv Fur Neurologie Und Psychiatrie, 162(4), 171–173. https://doi.org/10.4414/sanp.2011.02270

Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, & Putzki N. (2010). Corpus callosum index and long-term disability in multiple sclerosis patients. Journal of Neurology, 257(8), 1256–1264. https://doi.org/10.1007/s00415-010-5503-x

Putzki N, Yaldizli O, Bühler R, Schwegler G, Curtius D, & Tettenborn B. (2010). Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: Results from a multicenter study in Switzerland. European Neurology, 63(2), 101–106. https://doi.org/10.1159/000276400

Gasperini, Claudio, Ruggieri, Serena, & Pozzilli, Carlo. (2010). Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets. Therapeutics and Clinical Risk Management, 6, 391–399. https://doi.org/10.2147/tcrm.s6639

Papadopoulou, Athina, D’Souza, Marcus, Kappos, Ludwig, & Yaldizli, Ozgür. (2010). Dimethyl fumarate for multiple sclerosis. Expert Opinion on Investigational Drugs, 19(12), 12–1603. https://doi.org/10.1517/13543784.2010.534778

Menegola,M, Papadopoulou,A, Traud,S, Gass,A, Kappos,L, Radue,EW, & Yaldizli,O. (2010). Magnetic resonance imaging predictors of the persistence of T1 black holes in multiple sclerosis patients. ECTRIMS 2010, 316.

Yaldizli,O, Penner,IK, Frontzek,K, Madoerin,P, Naegelin,Y, Schaellebaum,M, Amann,M, Papadopoulou,A, Calabrese,P, Radue,EW, Kappos,L, & Gass,A. (2010). Regional corpus callosum atrophy, cognitive dysfunction and fatigue in multiple sclerosis patients. ECTRIMS 2010, 809.

Yaldizli O, Kumar M, Vago S, Kreuzfelder E, Limmroth V, & Putzki N. (2009). Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis. European Neurology, 62(6), 321–326. https://doi.org/10.1159/000236375

Yaldizli O, & Tettenborn B. (2009). [After lymph node biopsy. Pain and weakness in the right shoulder]. MMW Fortschritte der Medizin, 151(39), 5.

Obermann M, Küper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, Koutsilieri E, Arendt G, Diener HC, Maschke M, & German Competence Network HIV/AIDS. (2009). Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. Journal of Neurology, 256(6), 948–953. https://doi.org/10.1007/s00415-009-5052-3